 View printer-friendly version | ||||||||||||||
| << Back | ||||||||||||||
| Cell Therapeutics, Inc. (CTI) to update Pixuvri® launch and pacritinib pivotal trial status at the Annual Rodman & Renshaw Global Investment Conference | ||||||||||||||
The presentation with slides will be webcast live and available for replay after the presentation. The webcast can be accessed at www.celltherapeutics.com. Annual CTI presentation: Starlight North,
SOURCE |
